Collagen Peptides: The Hidden Winner of the GLP-1 Boom

Collagen peptides are short protein fragments derived from collagen, the primary structural protein found in skin, bones, and connective tissue. In 2026, the demand for collagen peptides is surging due to the GLP-1 drug revolution led by Semaglutide and Tirzepatide, which are transforming both medical treatments and health supplement markets.

Why Collagen Peptides are Trending with GLP-1 Drugs like Semaglutide

Collagen peptides benefit from the GLP-1 boom because drugs like Semaglutide and Tirzepatide cause rapid weight loss, often leading to side effects such as muscle loss, skin sagging, and joint stress. As a peptide hormone, GLP-1 signals fullness to the brain; these medications mimic this effect to reduce calorie intake. Collagen supplementation may address three specific side effects associated with this significant weight loss:

• Muscle loss: Studies indicate that 20-47% of weight lost during GLP-1 therapy can be muscle mass. Collagen peptides support muscle protein synthesis, the biological process of building muscle tissue.
• Skin sagging: Rapid fat loss often results in loose skin. Collagen serves as the essential structural protein for maintaining skin elasticity.
• Joint stress: Collagen peptides are traditionally utilized to support joint and bone health during physical changes.

Market Growth: Collagen Peptide Industry Forecast for 2026-2036

The global collagen peptide market is valued at $2.8 billion in 2026 and is projected to reach $7.0 billion by 2036, representing a compound annual growth rate (CAGR) of 9.7% (Future Market Insights, March 2026). Alternative estimates from Spherical Insights place the 2026 value at $3.3 billion with an 11.46% CAGR through 2035.

The GLP-1 drug trend is a primary growth driver for the industry. The muscle preservation functional foods market for weight-loss drug users was valued at $0.8 billion in 2025 and is expected to reach $6.9 billion by 2034 - a CAGR of 27.1% (ResearchIntelo, June 2026). Collagen peptides are a fundamental ingredient in these specialized products.

Natural GLP-1 Stimulation: Can Collagen Peptides Increase Hormone Secretion?

Yes. Rousselot, a leading collagen manufacturer, has developed Nextida GC, a patented collagen peptide ingredient designed to boost the body's natural GLP-1 secretion. At the Natural Products Expo West 2026, the company showcased two distinct product lines for different consumer needs:

• Peptan: Established collagen peptides for skin, bone, and muscle health - now specifically marketed to GLP-1 medication users.
• Nextida GC: A patented collagen peptide ingredient, with global patents, engineered to increase endogenous GLP-1 secretion. Two clinical studies have already been completed.

"We created a specific collagen composition that enhances GLP-1 secretion more effectively than other collagen compositions we tested," Dr. Catarina Silva, science integration manager at Rousselot, told Nutrition Insight.

Practical Benefits and Protein Requirements for GLP-1 Users

For GLP-1 users, targeted collagen products are becoming widely available in formats like powders, ready-to-drink (RTD) shakes, and functional foods. It is important to note that collagen peptides are not a complete protein because they lack certain essential amino acids. While they support skin and connective tissue during rapid weight loss, they do not replace a balanced intake of high-quality protein.

If you use GLP-1 medications, prioritize reaching your total protein goals - typically at least 1.2 g per kg of body weight. The reverse-dose calculator can help you monitor your intake. Collagen peptides can then serve as a targeted supplement for skin and joints. You can explore various types in the peptide library.

This is not medical advice. This article is for informational purposes only and does not replace individual nutritional counseling or medical supervision.